Bank Julius Baer & Co
BSTC

Bank Julius Baer & Co’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Bank Julius Baer & Co’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-50
Closed -$3K – 877
2020
Q3 		$3K Buy
+50
New +$3.09K ﹤0.01% 718

Other funds holding BSTC

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Bank Julius Baer & Co's BSTC Position: Q4 2020 in Review

Bank Julius Baer & Co sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 50 shares — an estimated $3K sold.

Bank Julius Baer & Co first reported a position in BSTC in Q3 2020 and held it in 1 quarter. The position peaked at $3K in Q3 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

  • Bank Julius Baer & Co reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
  • Bank Julius Baer & Co sold 50 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $3K.
  • Bank Julius Baer & Co first reported a position in BioSpecifics Technologies Corp. in Q3 2020 and held it in 1 quarter.
  • Bank Julius Baer & Co's BioSpecifics Technologies Corp. position peaked at $3K in Q3 2020.
  • 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Bank Julius Baer & Co's 13F filing for Q4 2020, filed 12 Feb 2021.